国药一致：公司主营业务为医药分销和医药零售，暂无转型计划

Core Viewpoint - The company, China National Pharmaceutical Group Corporation (国药一致), has no plans to transition into the molecular diagnostics sector, maintaining its focus on pharmaceutical distribution and retail [2] Company Summary - The main business of the company is pharmaceutical distribution and retail [2] - The company responded to an investor inquiry regarding potential transformation into the molecular diagnostics sector, confirming that there are currently no plans for such a transition [2]